Anna Ljung
board of director
Moberg Pharma
Sweden
Biography
Born 1980. Has worked for the company since 2006. Anna Ljung has served as the CFO of Athera Biotechnologies AB and Lipopetide AB, and worked as an independent consultant in the field of technology licensing. Shareholding: 12 000 shares and 80 000 employee stock options (80 000 shares may be subscribed to, based on the employee stock options).
Research Interest
medicine
